A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...
The drug is RI-AG03, and it's a peptide inhibitor (a blocker of proteins). In tests on fruit flies and human cells, it has ...
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
The increasing knowledge on how protein tau is organized in live cells has shown that the protein forms nanometer-sized ...
The compound, called RI-AG03, is a novel peptide inhibitor—a short chain of amino acids designed to block the activity of specific proteins. In fruit fly models and lab experiments on human ...
An international team of researchers has made a significant breakthrough in Alzheimer's drug development with the ...
In a promising breakthrough, an international team of researchers from the UK, US, and Japan has developed a new Alzheimer's ...